Implementation of a controlled human infection model for evaluation of HCV vaccine candidates-Reference-Cited by-同舟云学术

Implementation of a controlled human infection model for evaluation of HCV vaccine candidates

Published:2023-04-17 Issue:5 Volume:77 Page:1757-1772
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Barnes Eleanor,Cooke Graham S.,Lauer Georg M.,Chung Raymond T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32632

Reference103 articles.

1. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination;BMC Med,2019

2. The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries;J Virus Erad,2017

3. Impact of COVID‐19 on global HCV elimination efforts;J Hepatol,2021

4. Effect of COVID‐19 on viral hepatitis services in Pakistan;Lancet Gastroenterol Hepatol,2021

5. A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross‐genotype neutralizing antibodies in humans;PloS One,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk;Immunity & Ageing;2023-11-17

2. Hepatitis C;The Lancet;2023-09

3. Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations;Clinical Infectious Diseases;2023-08-14

4. Ethics of Controlled Human Infection Studies With Hepatitis C Virus;Clinical Infectious Diseases;2023-08-14

5. Chemoprevention in hepatocellular carcinoma;Current Hepatology Reports;2023-07-18